SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

Accelerate Diagnostics Q1 EPS $(0.390) Misses $(0.380) Estimate, Sales $2.342M Beat $2.270M Estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.390) per share which missed the analyst consensus estimate of $(0.380) by 2.63 percent. This is a 2.5 percent increase over losses of $(0.400) per

Benzinga · 05/07/2020 20:26

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.390) per share which missed the analyst consensus estimate of $(0.380) by 2.63 percent. This is a 2.5 percent increase over losses of $(0.400) per share from the same period last year. The company reported quarterly sales of $2.342 million which beat the analyst consensus estimate of $2.270 million by 3.17 percent. This is a 33.83 percent increase over sales of $1.750 million the same period last year.